Diabetes, heart surgery and the peripheral arteries;Diabetes, herzchirurgie und periphere gefäße

Clinical Research in Cardiology

Volumn 95, Issue 1 SUPPL., 2006, Pages

  Diehm, C ^a   Lawall, H ^a  

^a Klinikum Karlsbad Langensteinbach   (Germany)

Author keywords

Diabetes; Diabetic foot syndrome; PAD; Peripheral arterial disease

Indexed keywords

ARTERY DISEASE; ARTERY THROMBOSIS; ATHEROSCLEROSIS; CLAUDICATION; CORONARY ARTERY BYPASS GRAFT; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART SURGERY; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PREVALENCE; RECOGNITION; REVIEW; STROKE; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; SYSTEMIC DISEASE; THEORY;

ATHEROSCLEROSIS; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES COMPLICATIONS; HUMANS; INTERMITTENT CLAUDICATION; PERIPHERAL VASCULAR DISEASES; PREVALENCE; STROKE;

EID: 31544467542     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-1123-y     Document Type: Review

References (17)

1. American Diabetes Association (1997) Aspirin therapy in diabetes. Diabetes Care 20:1772-1773
2. Breddin HK, Krzywanek HJ, Althoff P, Schöffling K, Überla K (1986) PARD: Platelet aggregation as a risk factor in diabetes. Results of a prospective study. Klin Wochenschr 64:1042-1048
3. CAPRIE Steering Committee (1996) A randomised blinded trial of Clopidogrel versus Aspirin in Patients at Risc of Ischaemic Events (CAPRIE). Lancet 348:1329-1339
4. Chantelau E (2001) Does oral anticoagulation improve femoropedal graft patency in diabetic patients? Lessons from the Dutch BOA Study. VASA Suppl.58:47-49
5. Davi G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci GG, Ciabattoni G, Patrono C (1997) Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation 96(1):69-75
6. Dutch Bypass Oral anticoagulants or Aspirin Study Group (2000) Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery: a randomised trial. The Lancet 355:346-351
7. ETDRS Investigators (1992) Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 268:1292-1300
8. Ganda O, Arkin CF (1992) Hyperfibrinogenemia: an important rise factor for vascular complications in diabetes. Diabetes Care 15:1245-1250
9. Gosk-Bierska I, Adamiec R, Alexewicz P, Wysokinski WE (2002) Coagulation in diabetic and non-diabetic claudicants. Int Angiol 21:128-133
10. Jung F, Kiesewetter H, Körbel N, Wenzel E (1986) Microcirculatory and rheological alterations in type-I diabetes mellitus. Angio Archiv 12:27
11. Lawall H, Angelkort B (1999) Correlation between rheological parameters and erythrocyte velocity in nailfold capillaries in patients with diabetes mellitus. Clin Hemo Microcirc 20:41-47
12. Steering Committee of the Physicians Health Study Group (1989) Final report on the Aspirin component on the ongoing Physicians Health Study. N Engl J Med 321:129-135
13. Regensteiner JG, Hiatt HW (2002) Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med 112:49-57
14. Trautner C, Haastert B, Spraul M, Giani G, Berger M (2001) Unchanged incidence of lower-limb amputations in a German setting 1990-1998. Diabetes Care 24:855-859
15. Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis HK, Gries FA (1995) Intravasale Plättchenaktivierung bei Typ-I-Diabetes. Diabetes 44:890-894
16. Veves A, Donaghue VM, Sarnow MR, Giurini JM, Campbell DR, LoGerfo FW (1996) The impact of hypoxia by revascularisation on the peripheral nerve function in diabetic patients. Diabetologia 39:344-348
17. Woelfle KD, Bruijnen H, Loeprecht H (2001) Infrapopliteal arterial occlusive disease in diabetics with critical foot ischaemia: The role of distal-origin bypass grafts. VASA Suppl 58:40-43